CytomX Therapeutics, Inc. - Common Stock (CTMX)
CUSIP: 23284F105
Q2 2020 13F Holders as of 30 Jun 2020
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 169,491,059
- Total 13F shares
- 37,758,348
- Share change
- +1,679,817
- Total reported value
- $314,514,192
- Price per share
- $8.33
- Number of holders
- 133
- Value change
- +$15,532,613
- Number of buys
- 78
- Number of sells
- 48
Quarterly Holders Quick Answers
What is CUSIP 23284F105?
CUSIP 23284F105 identifies CTMX - CytomX Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 23284F105:
Top shareholders of CTMX - CytomX Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
2.3%
|
3,940,778
|
$30,225,000 | — | 31 Mar 2020 | |
| BVF INC/IL |
13F
|
Company |
2.3%
|
3,921,973
|
$30,082,000 | — | 31 Mar 2020 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
1.9%
|
3,253,923
|
$24,958,000 | — | 31 Mar 2020 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
1.6%
|
2,772,426
|
$21,265,000 | — | 31 Mar 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.6%
|
2,710,539
|
$20,789,000 | — | 31 Mar 2020 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.3%
|
2,208,000
|
$16,935,000 | — | 31 Mar 2020 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
0.63%
|
1,066,791
|
$8,182,000 | — | 31 Mar 2020 | |
| STATE STREET CORP |
13F
|
Company |
0.58%
|
986,948
|
$7,570,000 | — | 31 Mar 2020 | |
| MPM BioImpact LLC |
13F
|
Company |
0.5%
|
855,437
|
$6,561,000 | — | 31 Mar 2020 | |
| FMR LLC |
13F
|
Company |
0.49%
|
828,607
|
$6,355,000 | — | 31 Mar 2020 | |
| FIRST MANHATTAN CO. LLC. |
13F
|
Company |
0.47%
|
794,924
|
$6,097,000 | — | 31 Mar 2020 | |
| S.c.a. Candriam |
13F
|
Individual |
0.44%
|
741,144
|
$6,021,000 | — | 31 Mar 2020 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.43%
|
720,968
|
$5,530,000 | — | 31 Mar 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.42%
|
705,187
|
$5,408,000 | — | 31 Mar 2020 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.4%
|
686,398
|
$5,265,000 | — | 31 Mar 2020 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.35%
|
593,667
|
$4,552,000 | — | 31 Mar 2020 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.34%
|
575,420
|
$4,413,000 | — | 31 Mar 2020 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.31%
|
522,652
|
$4,008,000 | — | 31 Mar 2020 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.29%
|
487,700
|
$3,741,000 | — | 31 Mar 2020 | |
| Burrage Capital Management LLC |
13F
|
Company |
0.28%
|
482,982
|
$3,463,000 | — | 31 Mar 2020 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.21%
|
352,584
|
$2,704,000 | — | 31 Mar 2020 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.2%
|
343,011
|
$2,631,000 | — | 31 Mar 2020 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.18%
|
300,000
|
$2,301,000 | — | 31 Mar 2020 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.17%
|
294,313
|
$2,257,000 | — | 31 Mar 2020 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.17%
|
283,323
|
$2,174,000 | — | 31 Mar 2020 | |
| Man Group plc |
13F
|
Company |
0.16%
|
272,410
|
$2,089,000 | — | 31 Mar 2020 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.16%
|
272,183
|
$2,087,000 | — | 31 Mar 2020 | |
| Granahan Investment Management, LLC |
13F
|
Company |
0.16%
|
265,673
|
$2,038,000 | — | 31 Mar 2020 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.14%
|
243,012
|
$1,864,000 | — | 31 Mar 2020 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.13%
|
216,564
|
$1,661,000 | — | 31 Mar 2020 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.12%
|
208,925
|
$1,602,000 | — | 31 Mar 2020 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.12%
|
202,106
|
$1,550,000 | — | 31 Mar 2020 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.12%
|
195,230
|
$1,498,000 | — | 31 Mar 2020 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.11%
|
178,935
|
$1,372,000 | — | 31 Mar 2020 | |
| Spark Investment Management LLC |
13F
|
Company |
0.1%
|
176,993
|
$1,357,000 | — | 31 Mar 2020 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.1%
|
176,013
|
$1,350,000 | — | 31 Mar 2020 | |
| Private Advisor Group, LLC |
13F
|
Company |
0.08%
|
141,177
|
$1,083,000 | — | 31 Mar 2020 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.08%
|
140,339
|
$1,076,000 | — | 31 Mar 2020 | |
| GREAT POINT PARTNERS LLC |
13F
|
Company |
0.08%
|
139,718
|
$1,072,000 | — | 31 Mar 2020 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.08%
|
138,048
|
$1,059,000 | — | 31 Mar 2020 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.07%
|
120,126
|
$921,000 | — | 31 Mar 2020 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.07%
|
117,393
|
$900,000 | — | 31 Mar 2020 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.06%
|
100,000
|
$767,000 | — | 31 Mar 2020 | |
| MOORE CAPITAL MANAGEMENT, LP |
13F
|
Company |
0.06%
|
100,000
|
$767,000 | — | 31 Mar 2020 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.06%
|
99,448
|
$763,000 | — | 31 Mar 2020 | |
| Congress Park Capital LLC |
13F
|
Company |
0.06%
|
98,611
|
$756,000 | — | 31 Mar 2020 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.06%
|
93,978
|
$718,000 | — | 31 Mar 2020 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.05%
|
91,800
|
$704,000 | — | 31 Mar 2020 | |
| Exane Asset Management |
13F
|
Company |
0.05%
|
87,876
|
$674,009 | — | 31 Mar 2020 | |
| Swiss National Bank |
13F
|
Company |
0.05%
|
86,900
|
$667,000 | — | 31 Mar 2020 |
Institutional Holders of CytomX Therapeutics, Inc. - Common Stock (CTMX) as of Q2 2020
As of 30 Jun 2020,
CytomX Therapeutics, Inc. - Common Stock (CTMX) was held by
133 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
37,758,348 shares.
The largest 10 holders included
BlackRock Inc., BVF INC/IL, VANGUARD GROUP INC, PERCEPTIVE ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC, VICTORY CAPITAL MANAGEMENT INC, STATE STREET CORP, RTW INVESTMENTS, LP, GREAT POINT PARTNERS LLC, and Point72 Asset Management, L.P..
This page lists
133
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2020 vs Q1 2020 Across Filers
Q1 2020 holders
113
Q2 2020 holders
133
Holder diff
20
| Investor | Q1 2020 Shares | Q2 2020 Shares | Share Diff | Share Chg % | Q1 2020 Value $ | Q2 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.